Epidemiologic approaches to evaluating the potential for human papillomavirus type replacement postvaccination.

Abstract excerpt

Currently, 2 vaccines exist that prevent infection by the genotypes of human papillomavirus (HPV) responsible for approximately 70% of cervical cancer cases worldwide. Although vaccination is expected to reduce the prevalence of these HPV types, there is concern about the effect this could have on the distribution of other oncogenic types. According to basic ecological principles, if competition exists between ≥2...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Coinfection
• Share to Kaplan-Meier Estimate